<DOC>
	<DOCNO>NCT02064673</DOCNO>
	<brief_summary>This prospective study determine adjuvant use Curcumin improve recurrence-free survival .</brief_summary>
	<brief_title>Adjuvant Curcumin Assess Recurrence Free Survival Patients Who Have Had Radical Prostatectomy</brief_title>
	<detailed_description>This prospective study determine adjuvant use Curcumin improve recurrence-free survival patient radical prostatectomy compare placebo</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>radical prostatectomy adenocarcinoma prostate pathologically confirm T1T3 disease sign lymph node metastatic disease Eastern Cooperative Oncology Group ( ECOG ) status 02 adequate renal liver function plan receive adjuvant hormone radiation therapy life expectancy 3 year must exceed 3 month time surgery enrollment study T3b T4 node positive disease hormone therapy surgery history gallbladder problem gallstone , biliary obstruction radiation therapy primary treatment surgery antiplatelet anticoagulant agent history gastric duodenal ulcer hyperacidity syndrome</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>radical prostatectomy</keyword>
</DOC>